Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2026)

Aquestive Therapeutics' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.45 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 79.2% year-over-year to 1.45; the TTM figure through Mar 2026 stood at 4.97 (down 34.26% YoY), while the FY2025 annual figure was 6.39, down 130.94% from the prior year.
• Interest Coverage Ratio was 1.45 for Q1 2026 at Aquestive Therapeutics, up from 10.38 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.02 in Q2 2024 to a low of 10.38 in Q4 2025.
• Historically, Interest Coverage Ratio has averaged 4.33 across 5 years, with a median of 4.09 in 2025.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio soared 100.65% in 2024, then tumbled 20754.23% in 2025.
• A 5-year view of Interest Coverage Ratio shows it stood at 6.49 in 2022, then soared by 73.5% to 1.72 in 2023, then sank by 183.98% to 4.89 in 2024, then plunged by 112.46% to 10.38 in 2025, then surged by 86.05% to 1.45 in 2026.
• The last three Interest Coverage Ratio figures came in at 1.45 (Q1 2026), 10.38 (Q4 2025), and 4.13 (Q3 2025), per Business Quant data.